Predicted protein targets (top 19)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.41 |
| ▸ | CYP19A1 | P11511 | 1/20 | 0.36 |
| ▸ | PSMB5 | P28074 | 3/20 | 0.35 |
| ▸ | TSHR | P16473 | 2/20 | 0.35 |
| ▸ | ZDHHC20 | Q5W0Z9 | 2/20 | 0.32 |
| ▸ | SLC22A1 | O15245 | 1/20 | 0.32 |
| ▸ | CA12 | O43570 | 1/20 | 0.32 |
| ▸ | CA1 | P00915 | 1/20 | 0.32 |
| ▸ | CA2 | P00918 | 1/20 | 0.32 |
| ▸ | CA9 | Q16790 | 1/20 | 0.32 |
| ▸ | ACHE | P22303 | 1/20 | 0.31 |
| ▸ | HPGD | P15428 | 1/20 | 0.31 |
| ▸ | LMNA | P02545 | 1/20 | 0.31 |
| ▸ | ZDHHC2 | Q9UIJ5 | 1/20 | 0.31 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.30 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.30 |
| ▸ | GAA | P10253 | 1/20 | 0.30 |
| ▸ | PKM | P14618 | 1/20 | 0.30 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL20125902 | 0.84 | TSHR (0.49) | TDP1PSMB5TSHRZDHHC20ZDHHC2 | |
| SCHEMBL20125901 | 0.84 | TSHR (0.38) | PSMB5TSHRZDHHC20HPGDZDHHC2 | |
| SCHEMBL20128242 | 0.81 | TSHR (0.51) | TSHRZDHHC20HPGDLMNAZDHHC2 | |
| SCHEMBL13411271 | 0.80 | CA12 (0.42) | PSMB5TSHRZDHHC20CA12CA1 | |
| SCHEMBL23420159 | 0.79 | NAAA (0.50) | TSHRZDHHC20HPGDZDHHC2ALDH1A1 | |
| SCHEMBL20125983 | 0.79 | NAAA (0.50) | TSHRZDHHC20HPGDZDHHC2ALDH1A1 | |
| SCHEMBL20125938 | 0.78 | PSMB5 (0.38) | PSMB5TSHRZDHHC20HPGDLMNA | |
| SCHEMBL20125837 | 0.76 | ZDHHC20 (0.37) | TDP1PSMB5TSHRZDHHC20HPGD | |
| SCHEMBL22420161 | 0.75 | ZDHHC20 (0.39) | TDP1PSMB5TSHRZDHHC20CA12 | |
| SCHEMBL20125900 | 0.75 | PSMB5 (0.40) | PSMB5TSHRZDHHC20LMNAZDHHC2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20180127607-A1 | CURABLE COMPOSITION, CURABLE INK, ACCOMMODATING CONTAINER, IMAGE FORMING DEVICE, IMAGE FORMING METHOD, CURED MATTER, AND ACRYLAMIDE COMPOUND | RICOH COMPANY, LTD. (JP) | 2018-05-10 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20180127607-A1 | CURABLE COMPOSITION, CURABLE INK, ACCOMMODATING CONTAINER, IMAGE FORMING DEVICE, IMAGE FORMING METHOD, CURED MATTER, AND ACRYLAMIDE COMPOUND | CRYAA, CDKN1A, ACR | TDP1 1903/4885CYP19A1 1545/4885PSMB5 908/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.